Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.36 |
| ▸ | TERT | O14746 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25818422 | 0.99 | PLA2G2A (0.38) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL25818457 | 0.95 | PLA2G2A (0.37) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL25506465 | 0.94 | BACE1 (0.36) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL25818489 | 0.94 | BACE1 (0.36) | PIM1BACE1PLA2G2APLA2G4ATERT | |
| SCHEMBL22274543 | 0.94 | BACE1 (0.36) | PIM1BACE1PLA2G2APLA2G4ATERT | |
| SCHEMBL17524709 | 0.94 | PLA2G2A (0.38) | PIM1CSNK2A2CSNK2BPIM3PIM2 | |
| SCHEMBL30477002 | 0.93 | BACE1 (0.37) | PIM1BACE1TERTAHRALDH1A1 | |
| SCHEMBL23753687 | 0.93 | BACE1 (0.37) | PIM1BACE1TERTAHRALDH1A1 | |
| SCHEMBL24372505 | 0.92 | PGR (0.39) | PGRPLA2G2APLA2G4ATERTESR1 | |
| SCHEMBL31711734 | 0.92 | BACE1 (0.39) | PIM1CSNK2A2CSNK2BPIM3PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237518-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237518-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| WO-2023096318-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-06-01 | — | — | WO | disclosed |
| WO-2023085878-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-05-19 | — | — | WO | disclosed |
| WO-2021261962-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021261977-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021261907-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021182833-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2021-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174544-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY2, CYBA, AHR | PIM1 2796/4885CSNK2A2 584/4885CSNK2B 267/4885 |
| US-20240215441-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, AHR | PIM1 3822/4885CSNK2A2 163/4885CSNK2B 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.